These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 421198)
1. Patterns of urinary excretion of modified nucleosides. Gehrke CW; Kuo KC; Waalkes TP; Borek E Cancer Res; 1979 Apr; 39(4):1150-3. PubMed ID: 421198 [TBL] [Abstract][Full Text] [Related]
2. Relationship of urinary excretion of modified nucleosides to disease status in childhood acute lymphoblastic leukemia. Heldman DA; Grever MR; Miser JS; Trewyn RW J Natl Cancer Inst; 1983 Aug; 71(2):269-73. PubMed ID: 6576186 [TBL] [Abstract][Full Text] [Related]
3. Study of urinary nucleosides as biological marker in cancer patients analyzed by micellar electrokinetic capillary chromatography. Zheng YF; Xu GW; Liu DY; Xiong JH; Zhang PD; Zhang C; Yang Q; Lv S Electrophoresis; 2002 Dec; 23(24):4104-9. PubMed ID: 12481266 [TBL] [Abstract][Full Text] [Related]
4. Urinary excretion of modified nucleosides in patients with malignant mesothelioma. Fischbein A; Sharma OK; Selikoff IJ; Borek E Cancer Res; 1983 Jun; 43(6):2971-4. PubMed ID: 6850607 [TBL] [Abstract][Full Text] [Related]
5. Transfer RNA breakdown products in the urine of asbestos workers. Fischbein A; Sharma OK; Solomon S; Buschman F; Apell G; Kohn M; Selikoff IJ; Bekesi JG; Borek E Cancer Detect Prev; 1984; 7(4):247-52. PubMed ID: 6488216 [TBL] [Abstract][Full Text] [Related]
6. Altered RNA turnover in carcinogenesis. The diagnostic potential of modified base excretion. Marvel CC; Del Rowe J; Bremer EG; Moskal JR Mol Chem Neuropathol; 1994; 21(2-3):353-68. PubMed ID: 7522008 [TBL] [Abstract][Full Text] [Related]
7. Urinary excretion of modified nucleosides as biological marker of RNA turnover in patients with cancer and AIDS. Nakano K; Nakao T; Schram KH; Hammargren WM; McClure TD; Katz M; Petersen E Clin Chim Acta; 1993 Sep; 218(2):169-83. PubMed ID: 7508341 [TBL] [Abstract][Full Text] [Related]
8. Age-dependence of urinary normal and modified nucleosides in childhood as determined by reversed-phase high-performance liquid chromatography. Liebich HM; Müller-Hagedorn S; Bacher M; Scheel-Walter HG; Lu X; Frickenschmidt A; Kammerer B; Kim KR; Gérard H J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Jan; 814(2):275-83. PubMed ID: 15639449 [TBL] [Abstract][Full Text] [Related]
9. Analysis of urinary nucleosides as potential tumor markers in human colorectal cancer by high performance liquid chromatography/electrospray ionization tandem mass spectrometry. Hsu WY; Chen WT; Lin WD; Tsai FJ; Tsai Y; Lin CT; Lo WY; Jeng LB; Lai CC Clin Chim Acta; 2009 Apr; 402(1-2):31-7. PubMed ID: 19135043 [TBL] [Abstract][Full Text] [Related]
11. [Excretion of normal and modified RNA catabolites and creatinine in the urine as a function of nutrition in children]. Schöch G; Heller-Schöch G; Müller J; Clemens P; Holtgrewe A; Heddrich M Monatsschr Kinderheilkd; 1983 May; 131(5):259-63. PubMed ID: 6192333 [TBL] [Abstract][Full Text] [Related]
12. [Sodium excretion in children with lithogenic disorders]. Kovacević L; Kovacević S; Smoljanić Z; Peco-Antić A; Kostić N; Gajić M; Kovacević N; Jovanović O Srp Arh Celok Lek; 1998; 126(9-10):321-6. PubMed ID: 9863402 [TBL] [Abstract][Full Text] [Related]
13. Excretion pattern investigation of urinary normal and modified nucleosides of breast cancer patients by RP-HPLC and factor analysis method. Xu G; Schmid HR; Lu X; Liebich HM; Lu P Biomed Chromatogr; 2000 Nov; 14(7):459-63. PubMed ID: 11113924 [TBL] [Abstract][Full Text] [Related]
14. Comparison of RP-HPLC columns used for determination of nucleoside metabolic patterns in urine of cancer patients. Waszczuk-Jankowska M; Markuszewski MJ; Markuszewski M; Kaliszan R Bioanalysis; 2012 Jun; 4(10):1185-94. PubMed ID: 22651562 [TBL] [Abstract][Full Text] [Related]
15. Analysis, identification and determination of urinary modified nucleosides of cancer and AIDS patients. Nakano K; Yasaka T; Nakao T; Schram KH; Hammargren WM Nucleic Acids Symp Ser; 1990; (22):31-2. PubMed ID: 2101906 [TBL] [Abstract][Full Text] [Related]
16. Gas chromatography/mass spectrometric analysis of urinary nucleosides in cancer patients; potential of modified nucleosides as tumour markers. Langridge JI; McClure TD; el-Shakawi S; Fielding A; Schram KH; Newton RP Rapid Commun Mass Spectrom; 1993 Jun; 7(6):427-34. PubMed ID: 8329765 [TBL] [Abstract][Full Text] [Related]
17. [Value of increased urinary excretion of modified nucleosides as tumor markers in colon cancer]. Holstege A; Pauw M; Häring R; Kirchner R; Pausch J; Gerok W Verh Dtsch Ges Inn Med; 1986; 92():114-20. PubMed ID: 3811500 [No Abstract] [Full Text] [Related]
18. Development and validation of urinary nucleosides and creatinine assay by capillary electrophoresis with solid phase extraction. Szymańska E; Markuszewski MJ; Bodzioch K; Kaliszan R J Pharm Biomed Anal; 2007 Sep; 44(5):1118-26. PubMed ID: 17590562 [TBL] [Abstract][Full Text] [Related]
19. Analysis of modified nucleosides in the urine of patients with malignant cancer by liquid chromatography/electrospray ionization mass spectrometry. Li HY; Wang SM; Liu HM; Li J; Han D; Bu SS; Zhang MZ Rapid Commun Mass Spectrom; 2008 Oct; 22(20):3161-71. PubMed ID: 18798199 [TBL] [Abstract][Full Text] [Related]
20. Normal and modified urinary nucleosides represent novel biomarkers for colorectal cancer diagnosis and surgery monitoring. Feng B; Zheng MH; Zheng YF; Lu AG; Li JW; Wang ML; Ma JJ; Xu GW; Liu BY; Zhu ZG J Gastroenterol Hepatol; 2005 Dec; 20(12):1913-9. PubMed ID: 16336453 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]